People who are familiar with Republican presidential candidate Ron Paul have probably heard him speak about the need to end marijuana prohibition in the past. In fact, he mentions it quite often these days. Considering that only one other Republican candidate shares this opinion, it isn’t unusual to hear Paul bring this up in debate. Not only does this set him apart from the other candidates, but it is very telling to hear the rest of the field claim to be “conservatives” in favor of limited government and personal freedom, while supporting what is arguably the most intrusive, expensive, and wasteful government policy in existence.

This weekend, however, Ron Paul shared that message with a significant portion of America while speaking with Jay Leno on “The Tonight Show.” Judging from the audience response (not to mention a recent Gallup poll that shows a majority of voters support making marijuana legal), the need to end marijuana prohibition is becoming more obvious. [Read more →]

Share/Bookmark

Marijuana use by 8th, 10th and 12th grade students increased again in 2011, with more American teenagers now using marijuana for the fourth year in a row, according to numbers released today by the National Institute of Drug Abuse and the University of Michigan as part of the annual Monitoring the Future survey. In 2011, a slightly larger percent of high school seniors used marijuana in the last 30 days, while slightly less had used alcohol. Marijuana use continues to rise among youth despite the continued policy of arresting nearly a million people every year for marijuana violations.

“This report, once again, clearly demonstrates that our nation’s policymakers have their heads buried in the sand when it comes to addressing teen marijuana use,” said Rob Kampia, executive director of the Marijuana Policy Project.  “Political leaders have for decades refused to regulate marijuana in order to keep it out of the hands of drug dealers who aren’t required to check customer ID and have no qualms about selling marijuana to young people. The continued decline in teen tobacco and alcohol use is proof that sensible regulations, coupled with honest, and science-based public education can be effective in keeping substances away from young people. It’s time we acknowledge that our current marijuana laws have utterly failed to accomplish one of their primary objectives – to keep marijuana away from young people – and do the right thing by regulating marijuana, bringing its sale under the rule of law, and working to reduce the easy access to marijuana that our irrational system gives teenagers.”

Since the survey’s inception, overwhelming numbers of American teenagers have said marijuana was easy for them to obtain. According to the 2011 numbers, the use of alcohol – which is also regulated and sold by licensed merchants required to check customer ID – continued to decline among high school seniors, as did tobacco use.

“Arresting people for marijuana simply does not stop young people from using it, and it never will,” said Kampia. “It is time for a more sensible approach.”

To read the report, go here.

Share/Bookmark

At a hearing discussing the controversy surrounding Operation Fast & Furious, which allowed numerous firearms to be transferred to operatives for Mexican drug cartels, the attorney general got some questions on another drug war problem: the crackdown on medical marijuana.

Congressman Jared Polis (D-CO) asked Attorney General Holder if the Department of Justice intended to leave medical marijuana states alone as was promised in the Ogden Memo in 2009, as well as whether the recent crackdown in California on medical marijuana providers would be extended to other states.

Holder’s response was the same one that has been parroted by the administration again and again: medical marijuana is not an enforcement priority, given the department’s limited resources.

If that is true, what are the U.S. attorneys in California, Washington, Oregon, Montana, and Michigan doing? It seems as if they’ve been spending a lot of time and effort on a “low priority” lately.

Is Holder lying, or has he let the dogs at DOJ off the leash while he tries to explain why the federal government allowed guns to “walk” into Mexico that were later used to murder U.S. law enforcement agents? [Read more →]

Share/Bookmark

Last month, I had the pleasure of attending the CATO Institute’s “Ending the Global War on Drugs” conference. The event featured a number of prominent scholars and international leaders who spoke about the impact of the U.S.-led drug war, both here and abroad. One of my favorite speakers of the day was Dr. Harry Levine, professor of sociology at Queens College and the Graduate Center of the City University of New York. Dr. Levine has been researching the history and sociology of alcohol and drug policies for thirty years, and most recently has been working on the Marijuana Arrest Research Project, which collects and analyzes data on the immense number of marijuana possession arrests that the NYPD has made since 1996. (It should be noted here that possession of small amounts of marijuana has been decriminalized in the state of New York since 1977 — making it a violation, rather than a crime, so long as the marijuana is not in public view.) According to Levine, in New York City, misdemeanor marijuana possession accounts for more arrests than for any other crime, and because of the recent increase in the number of arrests, “it is appropriate to call this a marijuana arrest epidemic, and to describe what the NYPD has been doing as engaging in a marijuana arrest crusade.”

Dr. Levine’s lecture focused on the how and why of these marijuana possession arrests, explaining the various ways in which such arrests benefit police departments. In sum, police departments are pressured to show productivity, and these kinds of arrests are relatively safe and easy, involving “clean,” high-quality arrestees. Moreover, these arrests provide good training for rookies, deliver overtime pay for cops, allow supervisors to account for their underlings, and act as a net to get as many people into the system as possible, all at a cost borne entirely by the victims — the arrestees.

The federal government, according to Dr. Levine, actively supports these practices through the grant funding it provides to police departments. If departments receive these funds, they must justify how the money is spent, and what better, easier way to do that than with hordes of marijuana possession arrests? In short, this amounts to what LEAP board member (and fellow speaker at the conference) Leigh Maddox described as the “prostitution of the police peacekeeping mission for federal drug arrest dollars.” Dr. Levine suggests changing police productivity measures so as not to include small-time marijuana possession arrests. The punch line, Levine contends, is that rather than ending marijuana prohibition to put an end to marijuana arrests, it’s the inverse – by removing incentives for marijuana arrests we can move closer to ending marijuana prohibition.

But the answer of how to transform this tangled web of power, profit, incentive, and corruption remains unanswered. Sadly, such change is unlikely to be initiated by truth-telling law enforcement officers, or at least, active-duty ones. Last week, the New York Times reported on the consequences faced by two law enforcement officers who dared to express dissent with current drug policies. Both Bryan Gonzalez, a Border Patrol agent in New Mexico, and Joe Miller, a probation officer in Arizona, were fired from their positions — Gonzalez for questioning the war on drugs (specifically, the war on marijuana), Miller for expressing support for the decriminalization of marijuana. Fortunately, organizations like LEAP (Law Enforcement Against Prohibition) provide a forum for current and former members of law enforcement to express their frustrations with the harms and futility of our present drug policies and to support a system of drug regulation rather than prohibition. Unfortunately, many active-duty law enforcement members are reluctant or unwilling to speak out, and with good reason, in light of the sanctions faced by Gonzalez and Miller noted above.

On a positive note, the Wall Street Journal reported yesterday that low-level marijuana possession arrests have fallen 13 percent in New York City since a September directive issued from Police Commissioner Raymond Kelly cautioning officers to lay off the wrongful arrests of those possessing a small amount of marijuana concealed from public view. Hey … at least it’s something.

Share/Bookmark

Huge news broke today in the world of marijuana policy reform. Governors Christine Gregoire (D-WA) and Lincoln Chafee (I-RI) announced in a joint conference call that they had petitioned the federal government to reschedule marijuana. We can expect that this will produce headlines across the country. We can also expect that the coverage will tout this as a far more significant – and positive, from the perspective of patients – event than it actually is.

Before harping on the negative, let’s appreciate the positive aspect of the announcement. What we have here is two governors filing a petition with the federal government, backed by extensive documentation, saying that marijuana has an accepted medical use in our society. We have known this for years, but it is nice that it is becoming the general consensus. Unfortunately, that’s about all we have on the positive side of the ledger. After that, it is mostly bad news wrapped in good news clothing.

The misleading coverage started the moment the news broke, when The New York Times published its exclusive on the announcement. Describing how the governors wanted marijuana moved from Schedule I to Schedule II, the Times wrote, “Such a classification would allow pharmacies to dispense marijuana.” While technically true, in the sense that pharmacies cannot dispense Schedule I drugs, the reader is led to believe that marijuana would be available in pharmacies as soon as it is rescheduled. This is far from certain and could be a long way off on the horizon.

Given the long-held position of the federal government that it is the FDA that determines whether a substance is a medicine, it is likely that marijuana will not be available in pharmacies until it has made its way through the FDA approval process.* This is a process that could take up to a decade under the best of circumstances. But marijuana research does not exist in this country under the best of circumstance. In fact, as I wrote about recently in a Washington Post piece about stalled research on the use of marijuana for PTSD, it is almost impossible to conduct research on marijuana in this country. Moving marijuana to Schedule II will not change the rules under which marijuana research is (or is not) conducted.

Even if we were to ignore this not-so-minor problem about research and FDA approval, the governors clearly left the impression that they were pursuing rescheduling over embracing, implementing and defending existing medical marijuana laws in their own states. Yet they know that the rescheduling process will take years, perhaps more than a decade. In the meantime, patients in their states will suffer. The best Gov. Gregoire could say about this unfortunate delay during the press conference was that she was going to “encourage the federal government to not take nine years” to consider the petition. Woo. Hoo.

Finally, there is the additional matter of the specific request for Schedule II, a category of drugs defined under law as having a “high potential for abuse” that “may lead to severe psychological or physical dependence.” Drug like cocaine and morphine fall in this category. Marijuana does not belong there. At worst, marijuana should fall in Schedule III – where Marinol, which is synthetic THC is placed – a category of drugs that “may lead to moderate or low physical dependence or high psychological dependence.”

The New York Times article even included a quote from Governor Gregoire, suggesting that marijuana was not on the same level as the more dangerous Schedule II drugs.

Ms. Gregoire noted that many doctors believe it makes no sense to place marijuana in a more restricted category than opium and morphine. “People die from overdose of opiates,” she said. “Has anybody died from marijuana?”

No, Ms. Gregoire, they haven’t. And the harms from marijuana overall are quite limited. You and Mr. Chafee have come a long way today. Now it is time to step entirely out of the world of negative marijuana stereotypes and allow medical marijuana programs to move forward in your states. Rescheduling will happen eventually — and we commend you for petitioning for it — but you shouldn’t make patients in your state suffer in the meantime.

* The author would like to include a clarification, or perhaps it is a correction, here. After consulting with experts, he believes that a lengthy FDA approval process, meaning full trials to prove that marijuana is effective for a specific condition, would not be needed before marijuana could be available in pharmacies. However, there could still be a significant delay before marijuana appears in pharamacies after rescheduling (a process that could be quite lengthy itself). The DEA would have to license entities to cultivate the marijuana — a process likely to be slow, given the DEA’s history in this area. Then, maybe six months to a year later, the FDA would need to examine the marijuana produced by any entity to ensure that it is a consistent, reliable and pure product. And even after all of these steps have concluded, patients may have to deal with obstacles stemming from marijuana being listed as a Schedule II drug, including the fact that doctors and pharmacies would have to report every prescription to the DEA and that there would be no refills allowed, increasing the number of times patients would need to see doctors.

Share/Bookmark